1. Liang H, Fisher ML, Wu C, Ballon C, Sun X, Mills AA. PRMT5/WDR77 enhances the proliferation of squamous cell carcinoma via the p63-p21 axis Cancers, 16, 22, 2024
2. Fisher ML, Balinth S, Hwangbo Y, Wu C, Ballon C, Goldberg GL, Mills AA. Cancer-associated fibroblasts promote cancer stemness by inducing expression of the chromatin modifying protein CBX4 in squamous cell carcinoma Carcinogenesis, 18, 44, 485-496, 2023
3. Fisher ML, Balinth S, Mills AA. p63 in cancer: Importance and therapeutic opportunities Trends in Cell Biology, 33, 4, 280-292, 2023
4. Balinth S, Fisher ML, Hwangbo Y, Wu C, Ballon C, Sun X, Mills AA. EZH2 regulates a SETDB1/p63 axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma. Oncogene 41, 4130-4144, 2022
5. Fisher ML, Balinth S, Hwangbo Y, Wu C, Ballon C, Wilkinson J, Goldber GL, Mills AA. BRD4 regulates transcription factor p63 to drive a cancer stem cell phenotype in squamous cell carcinoma. Cancer Research 81, 24, 6246-6258, 2021
6. Fisher ML, Balinth S, and Mills, AA. P63-related signaling at a glance. Journal of Cell Science, 133, jcs228015, 2020
7. Wang Y, Leonard MK, Snyder DE, Fisher ML, Eckert RL, Kaetzel DM. NME1 drives expansion of melanoma cells with enhanced tumor growth and metastatic properties. Molecular Cancer Research, 17, 1665-1674, 2019
8. Fisher ML, Grun D, Adhikary G, Eckert RL. Sulforaphane reduces YAP/∆Np63α signaling to reduce cancer stem cell survival and tumor formation. Oncotarget, 8, 73407-73418, 2017
9. Kerr C, Szmacinski H, Fisher ML, Nance B, Lakowicz JR, Akbar A, Keillor JW, Wong TL, Godoy-Ruiz R, Toth EA, Weber DJ, Eckert RL. Transamidase site-targeted compounds alter the conformation of transglutaminase to reduce GTP binding activity and cancer stem cell survival. Oncogene 36, 2981-2990, 2017
10. Fisher ML, Adhikary G, Grun D, Kaetzel DM, Eckert RL. The Ezh2 Polycomb Group Protein Drives an Aggressive Phenotype in Melanoma Cancer Stem Cells and is a Target of Diet Derived Sulforaphane. Molecular Carcinogenesis 55, 2024-2036, 2016
11. Eckert RL, Fisher ML, Grun D, Adhikary G, Xu W, Kerr C. Transglutaminase as a cancer stem cell survival factor. 10, 947-958, 2015
12. Fisher ML, Keillor JW, Xu W, Eckert RL, Kerr C. Type II Transglutaminase is required for epidermal squamous cell carcinoma stem cell survival. Molecular Cancer Research 7, 1083-1094, 2015
13. Adhikary G, Grun D, Kerr C, Balasubramanian S, Rorke EA, Vemuri M, Boucher S, Bickenbach JR, Hornyak T, Xu W, Fisher ML, Eckert RL. Identification of a population of squamous cell carcinoma cells with enhanced potential for tumor formation. PLoS One 8, 12, e84324, 2013
